Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001641172-25-002927

Chief Scientific Officer acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bhowmick Neil Chief Scientific Officer 2025-01-01 Grant or award +14,000 1,139,983 D: show line 1 in the form
Loading xslF345X05/ownership.xml…